| 77-67-8 |
| Zarontin |
| Etosuximida |
| Ethosuxide |
| Pyknolepsinum |
| 2-Ethyl-2-methylsuccinimide |
| Ethosuccimide |
| Ethosuccinimide |
| Atysmal |
| Emeside |
| Suxilep |
| Suxinutin |
| 3-Ethyl-3-methylpyrrolidine-2,5-dione |
| Etosuximid |
| Petinimid |
| Zarondan |
| Aethosuximide |
| Thilopemal |
| Ethosuximidum |
| 3-Ethyl-3-methyl-2,5-pyrrolidinedione |
| 3-Methyl-3-ethylsuccinimide |
| 2-Methyl-2-ethylsuccinimide |
| CI-366 |
| 2,5-Pyrrolidinedione, 3-ethyl-3-methyl- |
| 3-Ethyl-3-methylsuccinimide |
| Etosuccimide |
| PM-671 |
| Succinimide, 2-ethyl-2-methyl- |
| CN-10,395 |
| PM 671 |
| alpha-Ethyl-alpha-methylsuccinimide |
| alpha-Methyl-alpha-ethylsuccinimide |
| 3-Methyl-3-ethylpyrrolidine-2,5-dione |
| gamma-Methyl-gamma-ethyl-succinimide |
| H 940 |
| H-490 |
| CN-10395 |
| (+-)-2-Ethyl-2-methylsuccinimide |
| NSC-64013 |
| DTXSID7023019 |
| gamma-ethyl-gamma-methyl-succinimide |
| 5SEH9X1D1D |
| CI 366 |
| CHEBI:4887 |
| NSC64013 |
| DTXCID203019 |
| Ethosuccimid |
| Ethylmethylsuccimide |
| Faes, Etosuximida |
| 3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one |
| RefChem:56507 |
| N03AD01 |
| (2RS)-2-Ethyl-2-methylsuccinimide |
| 201-048-7 |
| Petnidan |
| Ethymal |
| Pentinimid |
| Peptinimid |
| Succimitin |
| Zaraondan |
| Capitus |
| Mesentol |
| Pemalin |
| Simatin |
| Succimal |
| Suximal |
| Thetamid |
| Zarodan |
| Zartalin |
| Asamid |
| Etomal |
| Pemal |
| Ronton |
| Suxin |
| Piknolepsin |
| Epileo Petit MAL |
| Zarondan-Saft |
| Simatin(E) |
| C.I. 366 |
| Cl 366 |
| MFCD00072123 |
| 3-ethyl-3-methyl-pyrrolidine-2,5-dione |
| 3-Ethyl-3-methylpyrroline-2,5-dione |
| CHEMBL696 |
| .alpha.-Ethyl-.alpha.-methylsuccinimide |
| Aethosuccimidum |
| Etosuximide |
| (+/-)-2-ethyl-2-methylsuccinimide |
| s4626 |
| .gamma.-Methyl-.gamma.-ethylsuccinimide |
| Etosuccimide [DCIT] |
| Aethosuximide [German] |
| N-Ethyl methylsuccinimide |
| Ethosuximidum [INN-Latin] |
| Etosuximida [INN-Spanish] |
| Pyknole.psi.num |
| Piknole.psi.n |
| Zarontin (TN) |
| HSDB 1119 |
| SR-01000075863 |
| EINECS 201-048-7 |
| NSC 64013 |
| UNII-5SEH9X1D1D |
| BRN 0117054 |
| CAS-77-67-8 |
| NCGC00016320-01 |
| Prestwick_611 |
| Ethosuximide [USAN:USP:INN:BAN:JAN] |
| Spectrum_001385 |
| Ethosuximide (Standard) |
| Prestwick0_000165 |
| Prestwick1_000165 |
| Prestwick2_000165 |
| Prestwick3_000165 |
| Spectrum2_001483 |
| Spectrum3_000944 |
| Spectrum4_001051 |
| Spectrum5_001073 |
| ETHOSUXIMIDE [MI] |
| E0746 |
| (.+/-.)-Ethosuximide |
| ETHOSUXIMIDE [INN] |
| ETHOSUXIMIDE [JAN] |
| 2, 3-ethyl-3-methyl- |
| E 7138 |
| ETHOSUXIMIDE [HSDB] |
| ETHOSUXIMIDE [USAN] |
| ETHOSUXIMIDE [VANDF] |
| NCIOpen2_000014 |
| Lopac0_000532 |
| SCHEMBL34212 |
| BSPBio_000029 |
| ETHOSUXIMIDE [MART.] |
| KBioGR_001342 |
| KBioSS_001865 |
| 5-21-09-00595 (Beilstein Handbook Reference) |
| DivK1c_000218 |
| ETHOSUXIMIDE [USP-RS] |
| ETHOSUXIMIDE [WHO-DD] |
| ETHOSUXIMIDE [WHO-IP] |
| SPECTRUM1502196 |
| 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)- |
| SPBio_001465 |
| SPBio_001950 |
| BPBio1_000033 |
| GTPL7182 |
| orb1310343 |
| WLN: T5VMVTJ D2 D1 |
| SCHEMBL20541518 |
| Ethosuximide (JP18/USP/INN) |
| Ethosuximide, analytical standard |
| HMS500K20 |
| HY-B1378R |
| KBio1_000218 |
| KBio2_001865 |
| KBio2_004433 |
| KBio2_007001 |
| KBio3_002008 |
| NINDS_000218 |
| ETHOSUXIMIDE [ORANGE BOOK] |
| GLXC-06110 |
| HMS1568B11 |
| HMS1921L14 |
| HMS2092D20 |
| HMS2095B11 |
| HMS3261L05 |
| HMS3712B11 |
| HMS3885D12 |
| HMS5083G04 |
| Pharmakon1600-01502196 |
| ETHOSUXIMIDE [EP MONOGRAPH] |
| HY-B1378 |
| MSK10713 |
| ETHOSUXIMIDE [USP MONOGRAPH] |
| Ethosuximide 1.0 mg/ml in Methanol |
| Tox21_110370 |
| Tox21_500532 |
| BDBM50240424 |
| CCG-39217 |
| ETHOSUXIMIDUM [WHO-IP LATIN] |
| NSC758192 |
| 3-ethyl-3-methylazolidine-2,5-dione |
| AKOS005261742 |
| Tox21_110370_1 |
| CS-7976 |
| DB00593 |
| FE22867 |
| LP00532 |
| NSC-758192 |
| SDCCGSBI-0050515.P004 |
| .alpha.-Methyl-.alpha.-ethylsuccinimide |
| IDI1_000218 |
| NCGC00015418-02 |
| NCGC00015418-03 |
| NCGC00015418-04 |
| NCGC00015418-05 |
| NCGC00015418-06 |
| NCGC00015418-08 |
| NCGC00015418-09 |
| NCGC00015418-15 |
| NCGC00093923-01 |
| NCGC00093923-02 |
| NCGC00093923-03 |
| NCGC00093923-04 |
| NCGC00261217-01 |
| 3-Ethyl-3-methyl-2, 5-pyrrolidinedione |
| AS-16859 |
| DA-63296 |
| SBI-0050515.P003 |
| 2, 5-Pyrrolidinedione, 3-ethyl-3-methyl- |
| AB00052288 |
| EU-0100532 |
| NS00010826 |
| ST51037248 |
| C07505 |
| D00539 |
| D70258 |
| EN300-123801 |
| AB00052288_04 |
| zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione |
| Q421567 |
| SR-01000075863-1 |
| SR-01000075863-3 |
| SR-01000075863-5 |
| 3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide) |
| BRD-A99633051-001-04-7 |
| BRD-A99633051-001-05-4 |
| BRD-A99633051-001-07-0 |
| BRD-A99633051-001-08-8 |
| 3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide) |
| Z384975088 |
| 4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one |
| 2,5-PYRROLIDINEDIONE, 3-ETHYL-3-METHYL-, (+/-)- |
| Ethosuximide, European Pharmacopoeia (EP) Reference Standard |
| Ethosuximide, United States Pharmacopeia (USP) Reference Standard |
|
There are more than 10 synonyms. If you wish to see them all click here.
|